• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

定量骨SPECT/CT在软骨性骨肿瘤中的应用

Quantitative bone SPECT/CT applications for cartilaginous bone neoplasms.

作者信息

Kitajima Kazuhiro, Futani Hiroyuki, Tsuchitani Tatsuya, Takahashi Yoshiyuki, Tachibana Toshiya, Yamakado Koichiro

机构信息

Department of Radiology, Hyogo College of Medicine, Nishinomiya, Hyogo, Japan 1-1 Mukogawa-cho, Nishinomiya, Hyogo 663-8501 Japan.

出版信息

Hell J Nucl Med. 2020 May-Aug;23(2):133-137. doi: 10.1967/s002449912102. Epub 2020 Jul 27.

DOI:10.1967/s002449912102
PMID:32716404
Abstract

OBJECTIVE

To evaluate the ability of quantitative values obtained with bone single photon emission computed tomography/computed tomography (SPECT/CT) to differentiate benign from malignant cartilaginous bone neoplasms.

SUBJECTS AND METHODS

Bone SPECT/CT scans of 10 patients with 8 benign cartilaginous bone neoplasms (4 enchondromas, 1 periosteal chondroma, 1 osteochondroma, 1 bizarre parosteal osteochondromatous proliferation, 1 chondroblastoma) and 2 malignant cartilaginous bone neoplasms (1 periosteal chondrosarcoma, 1 chondrosarcoma) were retrospectively analyzed with maximum standardized uptake value (SUVmax), mean SUV (SUVmean), metabolic bone volume (MBV), and total bone uptake (TBU) of primary lesions.

RESULTS

Mean SUVmax of 8 benign and 2 malignant cartilaginous bone neoplasms were 1.93±1.02 (range 0.59-3.41) and 6.07±0.86 (5.46-6.67), respectively with no overlap (P=0.028). Mean SUVmean of those were 1.24±0.71 (range 0.36-2.36) and 4.05±0.30 (3.84-4.26), respectively with no overlap (P=0.00036). Mean MBV of those were 7.17±4.19 (range 3.17-13.77) and 10.29±10.05 (3.19-17.4), respectively with no significant difference (P=0.74). Mean TBU of those were 9.22±8.31 (range 1.15-23.61) and 43.19±43.7 (12.26-74.13), respectively with no significant difference (P=0.47).

CONCLUSION

Standardized uptake value obtained with bone SPECT/CT may be useful to differentiate benign from malignant cartilaginous bone neoplasms, thus helping the orthopedic surgeon towards the most appropriate treatment procedure.

摘要

目的

评估骨单光子发射计算机断层扫描/计算机断层扫描(SPECT/CT)获得的定量值区分良性与恶性软骨性骨肿瘤的能力。

受试者与方法

回顾性分析10例患者的骨SPECT/CT扫描结果,其中有8例良性软骨性骨肿瘤(4例内生软骨瘤、1例骨膜软骨瘤、1例骨软骨瘤、1例怪异型骨旁骨软骨瘤样增生、1例软骨母细胞瘤)和2例恶性软骨性骨肿瘤(1例骨膜软骨肉瘤、1例软骨肉瘤),分析原发灶的最大标准化摄取值(SUVmax)、平均SUV(SUVmean)、代谢骨体积(MBV)和总骨摄取量(TBU)。

结果

8例良性和2例恶性软骨性骨肿瘤的平均SUVmax分别为1.93±1.02(范围0.59 - 3.41)和6.07±0.86(5.46 - 6.67),无重叠(P = 0.028)。两者的平均SUVmean分别为1.24±0.71(范围0.36 - 2.36)和4.05±0.30(3.84 - 4.26),无重叠(P = 0.00036)。两者的平均MBV分别为7.17±4.19(范围3.17 - 13.77)和10.29±10.05(3.19 - 17.4),无显著差异(P = 0.74)。两者的平均TBU分别为9.22±8.31(范围1.15 - 23.61)和43.19±43.7(12.26 - 74.13),无显著差异(P = 0.47)。

结论

骨SPECT/CT获得的标准化摄取值可能有助于区分良性与恶性软骨性骨肿瘤,从而帮助骨科医生选择最合适的治疗方案。

相似文献

1
Quantitative bone SPECT/CT applications for cartilaginous bone neoplasms.定量骨SPECT/CT在软骨性骨肿瘤中的应用
Hell J Nucl Med. 2020 May-Aug;23(2):133-137. doi: 10.1967/s002449912102. Epub 2020 Jul 27.
2
Quantitative bone SPECT/CT applications for primary bone neoplasms.定量骨 SPECT/CT 在原发性骨肿瘤中的应用。
Hell J Nucl Med. 2021 Jan-Apr;24(1):36-44. doi: 10.1967/s002449912304. Epub 2021 Apr 20.
3
The value of skeletal standardized uptake values obtained by quantitative single-photon emission computed tomography-computed tomography in differential diagnosis of bone metastases.定量单光子发射计算机断层扫描-计算机断层扫描获得的骨骼标准化摄取值在骨转移鉴别诊断中的价值。
Nucl Med Commun. 2021 Jan;42(1):63-67. doi: 10.1097/MNM.0000000000001311.
4
Quantitative bone SPECT/CT: high specificity for identification of prostate cancer bone metastases.定量骨SPECT/CT:对前列腺癌骨转移的识别具有高特异性。
BMC Musculoskelet Disord. 2019 Dec 26;20(1):619. doi: 10.1186/s12891-019-3001-6.
5
Usefulness of quantitative bone SPECT/CT for medication-related osteonecrosis of the jaw in clinical settings.定量骨SPECT/CT在临床环境中对药物相关性颌骨坏死的应用价值。
Jpn J Radiol. 2022 May;40(5):492-499. doi: 10.1007/s11604-021-01226-1. Epub 2021 Dec 1.
6
Evaluation of bone metastasis burden as an imaging biomarker by quantitative single-photon emission computed tomography/computed tomography for assessing prostate cancer with bone metastasis: a phantom and clinical study.定量单光子发射计算机断层扫描/计算机断层扫描评估骨转移负荷作为骨转移前列腺癌的影像学生物标志物:体模和临床研究。
Radiol Phys Technol. 2020 Sep;13(3):219-229. doi: 10.1007/s12194-020-00571-6. Epub 2020 Jun 13.
7
Standardized uptake values of Tc-MDP in normal vertebrae assessed using quantitative SPECT/CT for differentiation diagnosis of benign and malignant bone lesions.采用定量 SPECT/CT 评估 Tc-MDP 标准化摄取值在正常椎体中对良恶性骨病变进行鉴别诊断的应用。
BMC Med Imaging. 2021 Feb 27;21(1):39. doi: 10.1186/s12880-021-00569-5.
8
Quantitative SPECT/CT for differentiating between enchondroma and grade I chondrosarcoma.定量 SPECT/CT 鉴别内生软骨瘤和 I 级软骨肉瘤。
Sci Rep. 2020 Jun 29;10(1):10587. doi: 10.1038/s41598-020-67506-4.
9
Test-retest repeatability of quantitative bone SPECT/CT.定量骨 SPECT/CT 的复测重复性。
Ann Nucl Med. 2021 Mar;35(3):338-346. doi: 10.1007/s12149-020-01568-2. Epub 2021 Jan 5.
10
F-FDG PET/CT in the evaluation of cartilaginous bone neoplasms: the added value of tumor grading.F-FDG PET/CT 评估软骨性骨肿瘤:肿瘤分级的附加价值。
Ann Nucl Med. 2019 Nov;33(11):813-821. doi: 10.1007/s12149-019-01392-3. Epub 2019 Aug 8.

引用本文的文献

1
Bizarre parosteal osteochondromatous proliferation (Nora lesion) involving the spine: a case report and systematic review.脊柱奇异骨旁骨软骨瘤性增殖(Nora 病变):病例报告及系统评价。
J Int Med Res. 2024 Jun;52(6):3000605241259752. doi: 10.1177/03000605241259752.
2
Quantitative Bone SPECT/CT of Central Cartilaginous Bone Tumors: Relationship between SUVmax and Radiodensity in Hounsfield Unit.中央软骨性骨肿瘤的定量骨SPECT/CT:SUVmax与亨氏单位中骨密度的关系
Cancers (Basel). 2024 May 22;16(11):1968. doi: 10.3390/cancers16111968.
3
An update on the imaging of diaphyseal aclasis.
骨干骺端离断症的影像学更新。
Skeletal Radiol. 2021 Oct;50(10):1941-1962. doi: 10.1007/s00256-021-03770-3. Epub 2021 Apr 1.